<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14</volume><submitter>Goertzen A</submitter><pubmed_abstract>Early detection of cancer typically facilitates improved patient outcomes; however, many cancers are not easily diagnosed at an early stage. One potential route for developing new, non-invasive methods of cancer detection is by testing for cancer-related volatile organic compounds (VOCs) biomarkers in patients' urine. In this review, 44 studies covering the use and/or identification of cancer-related VOCs were examined, including studies which examined multiple types of cancer simultaneously, as well as diverse study designs. Among these studies the most studied cancers included prostate cancer (29% of papers), lung cancer (22%), breast cancer (20%), and bladder cancer (18%), with a smaller number of studies focused on colorectal cancer, cervical cancer, skin, liver cancer and others. Impo</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>1448760</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11626232</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Potential urinary volatile organic compounds as screening markers in cancer - a review.</pubmed_title><pmcid>PMC11626232</pmcid><pubmed_authors>Kidane B</pubmed_authors><pubmed_authors>Goertzen A</pubmed_authors><pubmed_authors>Ahmed N</pubmed_authors><pubmed_authors>Aliani M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Potential urinary volatile organic compounds as screening markers in cancer - a review.</name><description>Early detection of cancer typically facilitates improved patient outcomes; however, many cancers are not easily diagnosed at an early stage. One potential route for developing new, non-invasive methods of cancer detection is by testing for cancer-related volatile organic compounds (VOCs) biomarkers in patients' urine. In this review, 44 studies covering the use and/or identification of cancer-related VOCs were examined, including studies which examined multiple types of cancer simultaneously, as well as diverse study designs. Among these studies the most studied cancers included prostate cancer (29% of papers), lung cancer (22%), breast cancer (20%), and bladder cancer (18%), with a smaller number of studies focused on colorectal cancer, cervical cancer, skin, liver cancer and others. Impo</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-04-08T15:23:09.914Z</modification><creation>2025-04-06T17:31:17.903Z</creation></dates><accession>S-EPMC11626232</accession><cross_references><pubmed>39655069</pubmed><doi>10.3389/fonc.2024.1448760</doi></cross_references></HashMap>